Sorbitan ester niosomes for topical delivery of rofecoxib

Indian Journal of Experimental Biology

Volumn 49, Issue 6, 2011, Pages 438-445

  Das, Malay K ^a   Palei, Narahari N ^a  

^a DIBRUGARH UNIVERSITY   (India)

Author keywords

Lipid film hydration technique; Niosomal gel; Niosomes; Rofecoxib; Topical delivery

Indexed keywords

CHOLESTEROL; CYCLOOXYGENASE 2 INHIBITOR; DRUG CARRIER; HEXOSE; LACTONE; LIPOSOME; ROFECOXIB; SULFONE;

ANIMAL; ARTICLE; CHEMISTRY; DRUG DELIVERY SYSTEM; GEL; IN VITRO STUDY; METABOLISM; SKIN; SWINE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; CHOLESTEROL; CYCLOOXYGENASE 2 INHIBITORS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GELS; HEXOSES; LACTONES; LIPOSOMES; SKIN; SULFONES; SUS SCROFA;

SUIDAE;

EID: 79958034104     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ibrahim A A, Bosela A A, Ahmed S M & Mahrous G M, Proniosomes as a drug carrier for transdermal delivery of ketorolac, Euro J Pharm Biopharm, 59 (2005) 485.
2. Junginger H E, Hofland H E J & Bouwstra J A, Liposomes and niosomes interactions with human skin, Cosmet Toil, 106 (1991) 45.
3. Reddy D N & Udupa N, Formulation and evaluation of oral and transdermal preparations of flurbioprofen and piroxicam incorporated with different carriers, Drug Develop Ind Pharm, 19 (1993) 843.
4. Hofland H E J, Vandergeest R, Bodde H E, Junginger H E & Bouwstra J A, Estradiol permeation from nonionic surfactant vesicles through human stratum corneum in vitro, Pharm Res, 11 (1994) 659.
5. Schier H & Bouwstra J A, Liposomes and niosomes as topical drug carriers-dermal and transdermal drug delivery, J Control Rel, 30 (1994) 1.
6. Shahiwala A & Misra A, Studies in topical application of niosomally entrapped nimesulide, J Pharm Pharm Sci, 5 (2002) 220.
7. Soniwala M M, Patel P R, Mansuri N S, Parikh R K & Gohel M C, Various approaches in dissolution enhancement of rofecoxib, Indian J Pharm Sci, 67 (2005) 61.
8. Baboota S, Dhaliwal M & Kohli K, Physicochemical characterization, in vitro dissolution behaviour and pharmacodynamic studies of rofecoxib-cyclodextrin inclusion compounds. Preparation and properties of rofecoxib hydroxypropyl r-cyclodextrin inclusion complex: A technical note, AAPS Pharm Sci Tech, 6 (2005) E 83.
9. Das M K & Ahmed A B, Formulation and ex vivo evaluation of rofecoxib gel for topical application, Acta Pol Pharm, 64 (2007) 461.
10. Desai K G H, Enhance skin permeation of rofecoxib using topical microemulsion gel, Drug Develop Res, 63 (2004) 33.
11. Das M K & Ahmed A B, Skin permeation enhancement effect of ascorbic acid and triethylcitrate on rofecoxib, Malaysian J Pharm Sci, 6 (2008) 69.
12. Baillie A J, Florance A T, Hume L R, Muirhead G T & Rogersion A, The preparation and properties of niosomesnonionic surfactant vesicles, J Pharm Pharmacol, 37 (1985) 863.
13. Ruckmani K, Jayakar B & Ghosal S K, Nonionic surfactant vesicles (Niosomes) of cytarbine hydrochloride for effective treatment of leukemias: Encapsulation, storage and in vitro release, Drug Develop Ind Pharm, 26 (2000) 217.
14. Hayton W L & Chen T, Correlation of perfusate concentration for sample removal, J Pharm Sci, 71 (1982) 820.
15. Yoshioka T, Sternberg B & Florence A T, Preparation and properties of vesicles (niosomes) of sorbitan monoester (Span 20, Span 40 and Span 80) and a sorbitan trimester (Span 85), Int J Pharm, 105 (1994) 1.
16. Uchegbu I F & Vyas S P, Nonionic surfactant based vesicles (niosomes) in drug delivery, Int J Pharm, 172 (1998) 33.
17. Khan Z U & Kellaway I W, Differential scanning calorimetry of dimethylsulphoxide-treated human stratum corneum, Int J Pharm, 55 (1989) 129.